News

BioAscent is now managing 56,000 samples of Medivir's compound collection for their ongoing drug discovery activities.

Lab Innovations, returns for its sixth year providing professionals with offers in a wide variety of sectors including pharmaceuticals.

Scientists report that avocado seed husks, which are usually discarded along with the seed, are hidden gold mines packed with a previously unrecognized plethora of chemical compounds.

Researchers have identified a possible reason why some aggressive breast cancers are unresponsive to certain immunotherapy treatments, as well as a potential solution.

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

In determining which genes are conserved across species, the researchers also discovered a new gene that improves myelin repair.

CloudLIMS.com, has released a new pay-as-you-go LIMS called CloudLMS Lite to help biobanks and laboratories to keep track of their biospecimens and testing workflows.

A newly developed human blood-vessel-on-a-chip models the vascular barrier and reveals a new cell migration-based mechanism for fibrotic diseases.

ACD/Labs technology enables automatic prediction of 1H and 13C spectra, using their industry-leading NMR prediction tools, for compounds already in the database and for new compounds as they are added in future.

A Yale-led team of researchers has identified specific gene combinations that can cause the deadly brain cancer glioblastoma, using new technology that can also pinpoint triggers of other types cancers.